GTG — Genetic Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- AU$20.20m
- AU$16.85m
- AU$8.69m
2019 June 30th | C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.13 | 14.2 | 20.9 | 11.7 | 7.85 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.819 | 0.789 | 1.07 | 2.42 | 1.92 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.2 | 15.2 | 22.2 | 14.7 | 10.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.069 | 0.44 | 0.638 | 0.953 | 0.599 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3.27 | 15.6 | 23 | 20.8 | 14.9 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.49 | 1.4 | 1.41 | 3.81 | 3.31 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.49 | 1.64 | 1.44 | 4.37 | 3.69 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.77 | 14 | 21.5 | 16.4 | 11.2 |
Total Liabilities & Shareholders' Equity | 3.27 | 15.6 | 23 | 20.8 | 14.9 |
Total Common Shares Outstanding |